Migraine Management — Clinical Assessment & Treatment Plan

🔍 Key Clinical Issues to Address First

⚠️ 1. The Post-Sumatriptan Unilateral Numbness — Critical Safety Flag

Triptans are contraindicated in patients with known or suspected coronary artery or cerebrovascular disease due to risk of myocardial ischemia. Triptan use in patients with hemiplegic or basilar migraine carries risk of vasospastic stroke. (Management of Headache, p. 75)

• Is the unilateral numbness always on the same side? If yes, and if it is not part of the migraine prodrome/aura, this raises concern for a triptan-induced transient ischemic phenomenon or, less likely, a new hemiplegic component.
• If the numbness occurs outside of migraine attacks only after the drug, it is almost certainly a triptan vasoconstrictive side effect.
• The chest pain (monthly, brief, relieved by antacids) appears GI (esophageal spasm or GERD), not cardiac — but cardiac workup (ECG, lipid profile, blood pressure check) should be done before continuing triptans long-term, especially given age 49 + perimenopausal status approaching.

⚠️ 2. Flunarizine After 4–5 Years — Time to Reconsider

• She has been on Flunarizine 10 mg for 4–5 years — this is well beyond the recommended continuous use duration (typically 6 months, max 1–2 years before a drug holiday is considered)
• She has developed moderate weight gain — a known dose-dependent side effect of flunarizine
• Attacks are still occurring ~2x/month with 4 disability days/month — this represents inadequate prophylactic response
• Flunarizine has a risk of drug-induced depression with long-term use, which is concerning given her mild anxiety/low mood

✅ Recommendations

A. ACUTE TREATMENT OPTIMIZATION

• Faster onset than oral sumatriptan (dissolves on tongue — helpful with nausea/vomiting)
• Well-tolerated, lower rate of paresthesia than sumatriptan
• Alternative: Zolmitriptan 2.5 mg nasal spray — bypasses GI tract entirely (excellent when vomiting is present)

• Treats the nausea/vomiting
• Also enhances triptan absorption (gastroparesis during migraine slows oral drug uptake — this may partly explain why her sumatriptan takes 1.5 hours)
• This combination may cut her relief time from 90 minutes to 45–60 minutes

• Instruct her to take medication as early as possible — at the first sign of headache, not when pain is severe. This alone can dramatically improve outcomes.

B. PREVENTIVE THERAPY — RECOMMENDED CHANGES

🥇 First Choice: Topiramate 25–100 mg/day (titrate slowly)

• Level A evidence for migraine prophylaxis
• Bonus: causes weight loss (counteracts flunarizine weight gain)
• No kidney stones or cognitive complaints — her specific contraindications are absent
• Start at 25 mg at night, increase by 25 mg every 2 weeks to 50–100 mg
• Monitor: word-finding difficulty, paresthesia (usually mild), metabolic acidosis (rare)

🥈 Strong Alternative: Amitriptyline 10–25 mg nightly

• Addresses her mild anxiety, low mood, and insomnia simultaneously
• Particularly useful if attacks have a tension-type component or if sleep is poor
• Caution: weight gain (similar to flunarizine), dry mouth, morning sedation at higher doses
• Start 10 mg nightly; can go to 25–50 mg over weeks

Option if both are poorly tolerated: Propranolol 40–80 mg twice daily

• Well-established Level A prophylactic
• Useful in patients with mild hypertension/palpitations
• Avoid if she has asthma or significant depression (can worsen mood)
• Not ideal here given mild mood symptoms

Topiramate 50–100 mg/day (weight-neutral to weight-reducing, strong prophylactic efficacy) + low-dose Amitriptyline 10 mg nightly if sleep or mood needs addressing

C. TRIGGER MANAGEMENT

D. INVESTIGATIONS TO ORDER BEFORE FINALIZING

1. ECG + Lipid profile + Fasting glucose — cardiac screen before continuing any triptan (age 49, perimenopausal, monthly chest pain even if likely GI)
2. Blood pressure measurement — baseline before adding topiramate or propranolol
3. Thyroid function (TSH) — increasing migraine frequency in perimenopausal women can be thyroid-driven
4. Consider neuroimaging (MRI brain) only if red flags emerge — current history is consistent with primary migraine, no red flags described

E. ONE ADDITIONAL CLARIFICATION NEEDED

Is the unilateral numbness always on the same side of the body?

Summary Table

Best Sumatriptan Alternative for This Patient

First, Understanding What Went Wrong With Sumatriptan

The Triptan Landscape — Ranked for Her Specifically

"Rizatriptan and eletriptan are, on a population basis, the most efficacious of the triptans." Clinical efficacy is related more to t-max (time to peak plasma level) than potency or half-life — faster-acting = more effective.

✅ The Best Choice for Her: Eletriptan 40 mg

Why Eletriptan Wins for This Specific Patient

🥈 Strong Second Choice: Rizatriptan 10 mg (wafer/MLT)

• Dissolves on the tongue — no swallowing needed, ideal when nausea or vomiting is present
• Very fast onset (~45 min), on par with eletriptan for speed
• High 2-hour pain-free rates, superior to sumatriptan 50 mg in most comparative studies
• Generic rizatriptan wafers (Rizact-MD, Riz-MT) are widely available in India at low cost

The Complete Acute Attack Protocol (Revised)

What to Tell Her Specifically

1. Stop waiting for pain to be severe — the single most impactful change. Taking the triptan early (mild pain phase) improves pain-free rates dramatically, reduces the dose needed, and prevents central sensitisation from setting in.
2. The numbness she had was the drug, not her brain — but Eletriptan has a much lower chance of causing that same effect.
3. The cardiac screen (ECG + lipids) should be done before starting any new triptan — not because there is strong suspicion, but because she is 49, perimenopausal, and has monthly chest episodes that need to be documented as GI and not cardiac.
4. Never use eletriptan or any triptan more than 2–3 days/week to avoid medication overuse headache, which can paradoxically increase frequency over time.

Summary

Best choice: Eletriptan 40 mg — the only triptan with Level A evidence of superiority over sumatriptan in head-to-head trials, lower paresthesia/chest side effects, faster and more complete relief, available in India as Relpax or generic. Always combine with Domperidone 10 mg at onset. Take at first sign of headache, not at peak pain. Baseline ECG and lipid profile before switching.

Rizatriptan for This Patient — Dose, Formulation & The Numbness Question

1. Which Formulation: Rizact-MD (Wafer) or Normal Tablet?

Rizact-MD (Oro-Dispersible Wafer) — This is the right choice for her

2. What Dose — 5 mg or 10 mg?

Start with Rizatriptan 10 mg

• 10 mg is the effective dose — it consistently outperforms 5 mg in pain-free rates at 2 hours and sustained pain relief over 24 hours
• The 5 mg dose is used in two specific situations: patients on propranolol (propranolol doubles rizatriptan plasma levels, so 5 mg is mandated if both are used together) and patients who are very sensitive to triptan side effects on their first trial
• She is not on propranolol, has moderate-to-severe attacks with vomiting, and needs reliable fast relief — 10 mg is appropriate

First 1–2 attacks: try 10 mg and monitor whether any paresthesia occurs. If she gets mild paresthesia again (less likely with rizatriptan but possible), she can drop to 5 mg. If 10 mg is clean, stay there.

3. Will the Numbness Reduce or Go Away?

The honest answer: Very likely yes, and here is exactly why

"Triptans promote cranial vasoconstriction... whereas ditans act only at neural and not vascular targets."

But there is a more complete solution worth knowing:

"Ditans have no vascular effects because the 5-HT₁F receptor is located in the central and peripheral nervous system but not vasculature — the class unequivocally fills a gap in therapy for patients who cannot tolerate triptans."

Practical Summary for This Patient

Recommended Investigations — Full Panel

🫀 Group 1: Cardiac & Vascular Safety (Before Continuing Any Triptan)

If ECG or lipid profile shows anything concerning, a 2D Echo and cardiologist review should follow before any triptan is continued.

🧠 Group 2: Neuroimaging — Is It Needed?

"No necessity for neuroimaging in patients with headaches consistent with migraine, normal neurological examination, and no red flags."

🧪 Group 3: Routine Metabolic & Hormonal Panel

🩺 Group 4: Perimenopausal Hormonal Assessment

This panel is especially important because if she is entering perimenopause, estrogen-related migraine worsening is predictable — and management strategy changes (e.g., transdermal estrogen supplementation can stabilize levels and reduce migraine frequency in this subset).

👁️ Group 5: Eye Examination

📋 Monitoring Schedule After Starting New Medications

Summary — Priority Order

URGENT (before starting new medications):
1. ECG
2. BP measurement
3. Fasting lipid profile + glucose
4. TSH
5. Serum magnesium + Vitamin D3

IMPORTANT (within 2–4 weeks):
6. CBC, LFT, RFT, electrolytes, serum bicarbonate
7. FSH, LH, Estradiol
8. MRI Brain (with contrast) — given increasing frequency + sensory symptoms

ROUTINE:
9. Ophthalmology review (IOP + fundus) before topiramate
10. Urine routine + serum calcium